Previous studies have found that abnormalities in COX5A are associated with growth retardation, abnormal lactate metabolism and aging-related diseases such as Parkinson’s disease and Alzheimer’s disease (Liang et al., 2022; O'Hanlon et al., 2022; Torraco et al., 2022). Here, COX5A is linked to early-onset autosomal dominant Alzheimer disease.